87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Colorectal cancer risk factors important to consider for rescreening interval

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C
Researchers explore e-bikes for cancer recovery

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:
Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo
Overcoming glioblastoma resistance to chemotherapy

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &
Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in
Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels
Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si
Researchers find new way to 'starve' prostate cancer tumors at the cellular level

Researchers find new way to 'starve' prostate cancer tumors at the cellular level

byIndiana UniversityKirk Staschke and Noah Sommers, a Ph.D. student at the IU School of Medicine, at the microscope. Credit: Kirk StaschkeNew research by a team of Indiana University School of M

Researchers find new way to 'starve' prostate cancer tumors at the cellular level

byIndiana UniversityKirk Staschke and Noah Sommers, a Ph.D. student at the IU School of Medicine, at the microscope. Credit: Kirk StaschkeNew research by a team of Indiana University School of M
Proof-of-concept study bioengineers therapeutics for improved cancer treatment

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut
Molecular 'ZIP code' draws killer T cells to brain tumors

Molecular 'ZIP code' draws killer T cells to brain tumors

by Levi Gadye,University of California, San FranciscoProgramming tissue-sensing T cells to deliver therapeutics to the brain. Credit:Science(2024). DOI: 10.1126/science.adl4237UCSF s

Molecular 'ZIP code' draws killer T cells to brain tumors

by Levi Gadye,University of California, San FranciscoProgramming tissue-sensing T cells to deliver therapeutics to the brain. Credit:Science(2024). DOI: 10.1126/science.adl4237UCSF s